CAPITOL COUNSEL LLC for GLAXOSMITHKLINE LLC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Reauthorization of the Prescription Drug User Fee Act (FDUFA).
Foreign entity interest: GlaxoSmithKline (GSK) is wholly owned by GlaxoSmithKline PLC, as disclosed on Form LD-1.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY CARROLL | — |
| MONIQUE FRAZIER | — |
| JOHN MARTIN | — |
| CHARLES PATRICK MICHAELS | — |
Medicare/Medicaid MMM
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Reauthorization of the Prescription Drug User Fee Act (FDUFA).
Foreign entity interest: GlaxoSmithKline (GSK) is wholly owned by GlaxoSmithKline PLC, as disclosed on Form LD-1.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY CARROLL | — |
| MONIQUE FRAZIER | — |
| JOHN MARTIN | — |
| CHARLES PATRICK MICHAELS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.